Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report

Simple item page
dc.contributor.authorTodder, D.
dc.contributor.authorBaune, B.
dc.date.issued2007
dc.description.abstractThis report describes a patient suffering from panic disorder who developed repeated suicidal ideation specifically due to the treatment with Venlafaxine. A first suicide attempt years ago occurred while being treated with Venlafaxine. Subsequent treatment with SSRIs or other antidepressants involved no suicidal ideation. Re-commencement of Venlafaxine four years later immediately led to a second suicide attempt. This unwanted effect subsided immediately after switching to another SNRI (i.e. Duloxetine). The case report underlines the importance of onset of suicide risk in panic disorders due to specific antidepressants.
dc.description.statementofresponsibilityDoron Todder and Bernhard T Baune
dc.identifier.citationJournal of Medical Case Reports, 2007; 1(166):1-4
dc.identifier.doi10.1186/1752-1947-1-166
dc.identifier.issn1752-1947
dc.identifier.issn1752-1947
dc.identifier.orcidBaune, B. [0000-0001-6548-426X]
dc.identifier.urihttp://hdl.handle.net/2440/65819
dc.language.isoen
dc.publisherBioMed Central Ltd
dc.rights© 2007 Todder and Baune; licensee BioMed Central Ltd.
dc.source.urihttp://www.jmedicalcasereports.com/content/1/1/166
dc.titleRecurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Psychiatry publications